C4 Therapeutics (CCCC) Net Income Growth (1y) (2020 - 2026)
C4 Therapeutics (CCCC) Net Income Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 69,146.49 Bn | 69,146.20 Bn | - | -0.46% |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 475.42 Bn | 470.63 Bn | 1.35 Bn | 17,802.13% |
| 5 | Vertex Pharmaceuticals | 123.32 Bn | 116.08 Bn | 2.59 Bn | 59.59% |
| 6 | Regeneron Pharmaceuticals | 69.80 Bn | 61.04 Bn | 3.31 Bn | -10.08% |
| 7 | Belite Bio | 63.28 Bn | 63.28 Bn | - | - |
| 8 | Argenx Se | 56.67 Bn | 51.48 Bn | 1.41 Bn | 63.48% |
| 9 | Revolution Medicines | 38.15 Bn | 38.15 Bn | - | - |
| 10 | C4 Therapeutics | 450.72 Mn | 215.05 Mn | - | -4.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.27% |
| Dec 31, 2025 | 41.10% |
| Sep 30, 2025 | -30.41% |
| Jun 30, 2025 | -46.87% |
| Mar 31, 2025 | 7.19% |
| Dec 31, 2024 | 0.53% |
| Sep 30, 2024 | 8.77% |
| Jun 30, 2024 | 50.68% |
| Mar 31, 2024 | 18.46% |
| Dec 31, 2023 | 6.53% |
| Sep 30, 2023 | 15.40% |
| Jun 30, 2023 | 72.08% |
| Mar 31, 2023 | -9.99% |
| Dec 31, 2022 | -137.48% |
| Sep 30, 2022 | -29.47% |
| Jun 30, 2022 | -469.84% |
| Mar 31, 2022 | -50.78% |
| Dec 31, 2021 | 28.16% |
| Sep 30, 2021 | -13.04% |
| Jun 30, 2021 | -109.21% |